Cargando…
AP-1 Transcription Factors as Regulators of Immune Responses in Cancer
Immune check point blockade therapy has revolutionized the standard of cancer treatment and is credited with producing remarkable tumor remissions and increase in overall survival. This unprecedented clinical success however is feasible for a limited number of cancer patients due to resistance occur...
Autores principales: | Atsaves, Vasileios, Leventaki, Vasiliki, Rassidakis, George Z., Claret, Francois X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678392/ https://www.ncbi.nlm.nih.gov/pubmed/31340499 http://dx.doi.org/10.3390/cancers11071037 |
Ejemplares similares
-
Constitutive control of AKT-1 gene expression by JUNB / CJUN in ALK+ anaplastic large cell lymphoma: a novel crosstalk mechanism
por: Atsaves, Vassilios, et al.
Publicado: (2015) -
Suppression of Jab1/CSN5 induces radiation- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways
por: Pan, Yunbao, et al.
Publicado: (2012) -
Stat3 Contributes to Cancer Progression by Regulating Jab1/Csn5 Expression
por: Pan, Yunbao, et al.
Publicado: (2016) -
Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations
por: Zerdes, Ioannis, et al.
Publicado: (2018) -
ALK+ Anaplastic Large Cell Lymphoma (ALCL)-Derived Exosomes Carry ALK Signaling Proteins and Interact with Tumor Microenvironment
por: Chioureas, Dimitrios, et al.
Publicado: (2022)